MetLife stock trades at EUR 89.11 with USD 64.0 billion market cap
π MetLife traded at USD 99.45 on October 12, 2026, with a market cap of USD 64.0 billion.
π Mizuho lowered its price target for MetLife from USD 112.00 to USD 109.00 on October 7, 2026.
π MetLife is scheduled to publish third-quarter 2026 results on November 4, 2026.
π¦ The company operates in the Financials/Insurance sector with a P/E ratio of 19.09.
π The stock trades near its 52-week high of USD 100.93 despite lower-than-average trading volume.
πΌ MetLife's business includes employee benefits, retirement solutions, annuities, and asset management.
Bullish Signals
- MetLife is trading near the upper end of its 52-week range at USD 99.45, indicating strong relative performance compared to its yearly low of USD 67.33.
- Mizuho Securities retains an Outperform rating on MetLife despite lowering the price target, signaling continued confidence in the company's long-term prospects.
Risk Factors
- Mizuho lowered its price target for MetLife from USD 112.00 to USD 109.00, suggesting a slight reduction in near-term upside expectations.
- Trading volume on October 12 was significantly below average at 276,263 shares versus a typical daily average of over 3.3 million shares.
Full Analysis
MetLife Inc. (MET) traded at USD 99.45 on the NYSE on October 12, 2026, maintaining a market capitalization of USD 64.0 billion. The stock price sits near the upper end of its 52-week range between USD 67.33 and USD 100.93, though session volume was notably low at 276,263 shares compared to an average daily volume of over 3.3 million.
The company operates as a large insurance platform with significant exposure to employee benefits, retirement solutions, annuities, asset management, and international operations. Analysts view the stock at a P/E ratio of approximately 19.09, reflecting its valuation relative to earnings in the financial services sector.
Market sentiment saw a slight adjustment on October 7, 2026, when Mizuho Securities lowered its price target for MetLife from USD 112.00 to USD 109.00 while retaining an Outperform rating. The company is scheduled to release its third-quarter 2026 financial results on November 4, 2026, followed by an earnings call on November 5.
MetLife faces a modest headwind from the analyst target reduction, yet the stock remains positioned near its yearly high. Investors will be watching the upcoming Q3 earnings report for further guidance on the insurer's performance in benefits and international markets.